T3 Tablets

Liothyronine Sodium: The Active Thyroid Hormone

T3 Tablets by British Dragon contain Liothyronine Sodium — the synthetic form of triiodothyronine, the thyroid hormone responsible for directly regulating basal metabolic rate at the cellular level. T3 is categorically different from every other compound in the British Dragon catalog. It is not an anabolic steroid, not a peptide hormone, and not a selective receptor modulator. It is a thyroid hormone — the primary determinant of how quickly the body converts nutrients into energy, builds or breaks down tissue, and maintains core temperature.

The distinction between T3 (triiodothyronine) and T4 (thyroxine, Levothyroxine) is clinically significant: T4 is the storage and transport form of thyroid hormone, produced in large quantities by the thyroid gland and converted to active T3 in peripheral tissues as needed. T3 is the form that actually binds thyroid hormone receptors and produces metabolic effects. Exogenous Liothyronine (T3) bypasses the T4-to-T3 conversion step — delivering the active hormone directly, with faster onset and more predictable dose-response than Levothyroxine (T4) supplementation.

How T3 Increases Fat Loss — The Metabolic Rate Mechanism

Thyroid hormone receptors are expressed in virtually every metabolically active cell in the body. When T3 binds these receptors, it upregulates the transcription of genes responsible for metabolic enzyme production, mitochondrial activity, and substrate oxidation:

• Increases basal metabolic rate (BMR) — the calories burned at rest — by 10–40% depending on dose. This is the most directly fat-reducing effect: the body burns substantially more energy maintaining basic physiological functions at elevated T3 levels than at normal thyroid levels
• Accelerates glucose oxidation and glycogen turnover — carbohydrate metabolism increases, affecting insulin sensitivity and blood glucose dynamics at higher doses
• Directly stimulates lipolysis — fat cells release stored triglycerides into circulation at an accelerated rate for oxidation as fuel
• Increases protein turnover — this is the critical liability. Elevated T3 does not selectively burn fat. It increases the metabolism of all macronutrients simultaneously, including muscle protein. Without adequate anabolic protection, lean tissue loss is a direct and measurable consequence of T3 use at performance doses
• Enhances the thermogenic effect of other compounds — T3 amplifies the fat-burning output of catecholamines (adrenaline), Clenbuterol's beta-2 agonist activity, and human growth hormone's lipolytic effect

The Mandatory Pyramid Protocol — Why T3 Cannot Be Started or Stopped Abruptly

The most important operational requirement for T3 Tablets — and the aspect most frequently managed incorrectly — is the pyramid protocol. Unlike anabolic steroids where gradual dose escalation is a preference, for T3 it is a physiological necessity driven by two mechanisms:

• Starting too high produces severe cardiovascular and metabolic side effects — palpitations, tachycardia, excessive sweating, anxiety and tremors, and insomnia appear acutely when supraphysiological T3 is introduced abruptly. The body's tissues require adaptation time. Starting at 25 mcg/day and escalating by 25 mcg increments every 2 weeks respects this adaptation requirement
• Stopping abruptly causes rebound hypothyroidism — exogenous T3 suppresses the hypothalamic-pituitary-thyroid (HPT) axis throughout the cycle. The pituitary stops releasing TSH; the thyroid reduces its own T3 and T4 production. When exogenous T3 is stopped without a taper, the athlete is left with a suppressed thyroid and no exogenous replacement. The result is a period of frank hypothyroidism — weight gain, severe fatigue, cognitive impairment, depression, and cold intolerance lasting weeks until the HPT axis reactivates. The descending taper mirrors the pyramid entry — reducing dose by 25 mcg every 1–2 weeks until natural thyroid production resumes.

The standard performance pyramid across an 8-week cycle: weeks 1–2 at 25 mcg/day; weeks 3–4 at 50 mcg/day; weeks 5–6 at 75 mcg/day; week 7 at 50 mcg/day; week 8 at 25 mcg/day. This structure is not optional.

Dosing Protocol for T3 Tablets

• Starting dose: 25 mcg/day (1 tablet). Every cycle — regardless of experience — begins here. The thyroid system's sensitivity to exogenous T3 is individual and unpredictable, and the starting dose assesses tolerance before any escalation.
• Effective performance dose: 50–75 mcg/day (2–3 tablets). Produces significant metabolic acceleration with manageable side effects for most athletes. The 50 mcg level (2 tablets) is the most commonly settled upon dose — sufficient for pronounced fat loss support without the cardiovascular and catabolic intensity of 75 mcg and above.
• Maximum dose: 75–100 mcg/day. At 75–100 mcg/day the risk of cardiovascular side effects, skeletal muscle catabolism, and bone mineral loss increases significantly. This dose range requires robust anabolic protection, cardiac baseline monitoring, and cycle duration not exceeding 6 weeks at the peak.
• Dosing timing: Once daily in the morning (aligns with natural thyroid hormone circadian rhythm and avoids the insomnia risk of late-day T3 administration). At higher doses (75 mcg), splitting across morning and midday provides slightly more stable levels and reduces the intensity of peak cardiovascular effects.
• Pack supply: 100 tablets at 25 mcg each. A complete 8-week pyramid cycle (weeks 1–2 at 25 mcg, weeks 3–4 at 50 mcg, weeks 5–6 at 75 mcg, weeks 7–8 tapering) uses approximately 70 tablets — one pack covers a complete cycle with reserve.

Most Effective Combinations with T3 Tablets

• T3 Tablets (25–75 mcg/day pyramid) + Clenbuterol Tablets — the classic two-compound fat loss protocol combining the two most potent non-anabolic fat-burning agents through entirely different mechanisms. T3 elevates basal metabolic rate through thyroid receptor activation — increasing the caloric burn of every biological function at rest and during activity. Clenbuterol's beta-2 agonist activity drives thermogenesis through adrenergic receptor activation — a separate and synergistic mechanism. Together they create the broadest fat loss coverage available in a two-compound protocol.
• T3 Tablets (25–50 mcg/day) + Somatrobol (Human Growth Hormone) — the thyroid optimisation protocol for HGH cycles. Human growth hormone at performance doses (4–6 IU/day) significantly increases the body's demand for thyroid hormone — GH accelerates T4 to T3 conversion, but also increases the total thyroid hormone turnover rate. In athletes with normal thyroid function, high-dose HGH can produce a relative functional hypothyroidism that blunts HGH's full fat-loss potential. T3 at 25–50 mcg/day corrects this deficit, restoring optimal thyroid hormone availability and amplifying the lipolytic output of the HGH cycle.
• T3 Tablets (50–75 mcg/day) + Oxanabol Tablets + Testabol Enanthate — the protected fat loss cycle with anabolic base. Testosterone Enanthate at 300–400 mg/week provides the primary anabolic hormonal base — protecting muscle protein from T3-mediated catabolism through direct androgen receptor activation and IGF-1 elevation. Oxandrolone (Oxanabol Tablets) at 40–50 mg/day adds SHBG binding, nitrogen retention, and direct lean tissue preservation — creating the most complete muscle-protective environment possible for fat loss at elevated T3 doses.

Side Effects: Dose-Dependent Thyroid and Cardiovascular Effects

• Tachycardia and palpitations — the most commonly reported side effect. T3 directly increases heart rate through thyroid receptor activation in cardiac muscle. At 25–50 mcg/day, most athletes experience a mild resting heart rate elevation of 5–15 bpm. At 75–100 mcg/day, persistent tachycardia, palpitations, and premature contractions can occur. Athletes with elevated heart rate on cycle may consider Nebicard 5 mg under medical guidance. Athletes with pre-existing cardiac conditions must not use T3 at performance doses.
• Excessive sweating and heat intolerance — the elevated metabolic rate increases thermogenesis. Athletes running T3 at 50–75 mcg/day typically report pronounced sweating during training and at rest, increased body temperature, and reduced cold tolerance.
• Anxiety, tremors, and insomnia — dose-dependent CNS effects from elevated metabolic stimulation. Managing T3 timing (morning dosing only) and staying within the 50–75 mcg effective range reduces these effects significantly.
• Lean muscle catabolism — addressed below; the primary risk for athletes using T3 without anabolic protection.
• Bone mineral density reduction — prolonged supraphysiological T3 exposure contributes to bone turnover imbalance. Relevant for cycles exceeding 8–10 weeks at high doses.
• Rebound hypothyroidism if not tapered — the most operationally consequential risk. Requires strict adherence to the descending pyramid at cycle end.

The Lean Tissue Risk: What T3 Does to Muscle at Performance Doses

T3's protein catabolic effect is the compound's most important limitation and the primary determinant of how it should be integrated into any cycle:

• At 25 mcg/day (physiological replacement range), protein catabolism is minimal and approximately matches what a natural T3 level would produce — net neutral for lean tissue
• At 50–75 mcg/day (performance range), protein catabolism increases meaningfully. In a caloric deficit without anabolic protection, lean muscle loss alongside fat loss is measurable within 2–4 weeks
• The minimum anabolic protection for any T3 cycle at 50 mcg/day or above is a testosterone base at a performance dose. Testosterone's direct androgenic stimulation of muscle protein synthesis creates a counter-catabolic environment that significantly limits T3-induced lean tissue loss
• The addition of a nitrogen-retention-focused compound (Oxandrolone, Methenolone, Nandrolone) provides a second layer of lean tissue protection for athletes running T3 at the upper dose range

Conclusion

T3 Tablets by British Dragon represent the most direct pharmacological intervention available for elevating fat oxidation at the metabolic root level. Where Clenbuterol operates through adrenergic stimulation and anabolic steroids create an anabolic environment that indirectly supports fat loss through lean mass, T3 increases the rate at which every cell in the body processes energy — at rest, during training, and throughout recovery.

The mandatory pyramid protocol, the requirement for concurrent anabolic protection at performance doses, and the HPT axis management at cycle end distinguish T3 from most other compounds in operational complexity. Managed correctly — gradual escalation, appropriate dose ceiling, lean tissue protection, and careful taper — T3 Tablets deliver the most powerful metabolic acceleration available in a single oral compound, and a fat loss output that stacks productively with every compound in the British Dragon range that carries a fat loss component.